499 related articles for article (PubMed ID: 9744474)
21. Type 2 Gaucher disease occurs in Ashkenazi Jews but is surprisingly rare.
Aviner S; Garty BZ; Rachmel A; Baris HN; Sidransky E; Shuffer A; Attias J; Yaniv Y; Cohen IJ
Blood Cells Mol Dis; 2009; 43(3):294-7. PubMed ID: 19734074
[TBL] [Abstract][Full Text] [Related]
22. Gaucher disease: the origins of the Ashkenazi Jewish N370S and 84GG acid beta-glucosidase mutations.
Diaz GA; Gelb BD; Risch N; Nygaard TG; Frisch A; Cohen IJ; Miranda CS; Amaral O; Maire I; Poenaru L; Caillaud C; Weizberg M; Mistry P; Desnick RJ
Am J Hum Genet; 2000 Jun; 66(6):1821-32. PubMed ID: 10777718
[TBL] [Abstract][Full Text] [Related]
23. Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease.
Koprivica V; Stone DL; Park JK; Callahan M; Frisch A; Cohen IJ; Tayebi N; Sidransky E
Am J Hum Genet; 2000 Jun; 66(6):1777-86. PubMed ID: 10796875
[TBL] [Abstract][Full Text] [Related]
24. Frequency of carriers of chronic (type I) Gaucher disease in Ashkenazi Jews.
Matoth Y; Chazan S; Cnaan A; Gelernter I; Klibansky C
Am J Med Genet; 1987 Jul; 27(3):561-5. PubMed ID: 3631130
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic and genotypic heterogeneity in Gaucher disease type 1: a comparison between Brazil and the rest of the world.
Sobreira E; Pires RF; Cizmarik M; Grabowski GA
Mol Genet Metab; 2007 Jan; 90(1):81-6. PubMed ID: 16996765
[TBL] [Abstract][Full Text] [Related]
26. DNA mutational analysis of type 1 and type 3 Gaucher patients: how well do mutations predict phenotype?
Sidransky E; Bottler A; Stubblefield B; Ginns EI
Hum Mutat; 1994; 3(1):25-8. PubMed ID: 8118463
[TBL] [Abstract][Full Text] [Related]
27. Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity.
Clark LN; Nicolai A; Afridi S; Harris J; Mejia-Santana H; Strug L; Cote LJ; Louis ED; Andrews H; Waters C; Ford B; Frucht S; Fahn S; Mayeux R; Ottman R; Marder K
Mov Disord; 2005 Jan; 20(1):100-3. PubMed ID: 15517591
[TBL] [Abstract][Full Text] [Related]
28. Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease.
Schmitz M; Alfalah M; Aerts JM; Naim HY; Zimmer KP
Int J Biochem Cell Biol; 2005 Nov; 37(11):2310-20. PubMed ID: 15982918
[TBL] [Abstract][Full Text] [Related]
29. Increased incidence of Parkinson disease among relatives of patients with Gaucher disease.
Halperin A; Elstein D; Zimran A
Blood Cells Mol Dis; 2006; 36(3):426-8. PubMed ID: 16651014
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of Turkish Gaucher disease patients: identification of novel mutations in glucocerebrosidase (GBA) gene.
Emre S; Gürakan F; Yüce A; Rolf A; Scott R; Ozen H
Eur J Med Genet; 2008; 51(4):315-21. PubMed ID: 18586596
[TBL] [Abstract][Full Text] [Related]
31. The 1226G (N370S) Gaucher mutation among patients with Legg-Calve-Perthes disease.
Kenet G; Hayek S; Mor M; Lubetsky A; Miller L; Rosenberg N; Mosheiff R; Itzchaki M; Elstein D; Wientroub S; Zimran A
Blood Cells Mol Dis; 2003; 31(1):72-4. PubMed ID: 12850487
[TBL] [Abstract][Full Text] [Related]
32. Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated?
Fares F; Badarneh K; Abosaleh M; Harari-Shaham A; Diukman R; David M
Prenat Diagn; 2008 Mar; 28(3):236-41. PubMed ID: 18264947
[TBL] [Abstract][Full Text] [Related]
33. Bloom syndrome and Fanconi's anemia: rate and ethnic origin of mutation carriers in Israel.
Peleg L; Pesso R; Goldman B; Dotan K; Omer M; Friedman E; Berkenstadt M; Reznik-Wolf H; Barkai G
Isr Med Assoc J; 2002 Feb; 4(2):95-7. PubMed ID: 11876000
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of nine mutations among Jewish and non-Jewish Gaucher disease patients.
Horowitz M; Tzuri G; Eyal N; Berebi A; Kolodny EH; Brady RO; Barton NW; Abrahamov A; Zimran A
Am J Hum Genet; 1993 Oct; 53(4):921-30. PubMed ID: 8213821
[TBL] [Abstract][Full Text] [Related]
35. High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews.
Zimran A; Gelbart T; Westwood B; Grabowski GA; Beutler E
Am J Hum Genet; 1991 Oct; 49(4):855-9. PubMed ID: 1897529
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the glucocerebrosidase gene and mutation profile in 144 Italian gaucher patients.
Filocamo M; Mazzotti R; Stroppiano M; Seri M; Giona F; Parenti G; Regis S; Corsolini F; Zoboli S; Gatti R
Hum Mutat; 2002 Sep; 20(3):234-5. PubMed ID: 12204005
[TBL] [Abstract][Full Text] [Related]
37. The N370S mutation in the glucocerebrosidase gene of Portuguese type 1 Gaucher patients: linkage to the PvuII polymorphism.
Lacerda L; Amaral O; Pinto R; Aerts J; Sá Miranda MC
J Inherit Metab Dis; 1994; 17(1):85-8. PubMed ID: 8051940
[TBL] [Abstract][Full Text] [Related]
38. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N
Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604
[TBL] [Abstract][Full Text] [Related]
39. Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.
Stone DL; Tayebi N; Orvisky E; Stubblefield B; Madike V; Sidransky E
Hum Mutat; 2000; 15(2):181-8. PubMed ID: 10649495
[TBL] [Abstract][Full Text] [Related]
40. Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles.
Sawkar AR; Adamski-Werner SL; Cheng WC; Wong CH; Beutler E; Zimmer KP; Kelly JW
Chem Biol; 2005 Nov; 12(11):1235-44. PubMed ID: 16298303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
